What our research found
Wellmedr is an active U.S. cash-pay telehealth brand operated by WELLMEDR LLC. Florida corporate records show the company as active and list a St. Petersburg address that matches the current provider contact page.
The terms separate Wellmedr's technology and administrative role from medical care. They say independent clinicians deliver telehealth through OpenLoop or another U.S.-licensed partner network and decide whether a prescription is clinically appropriate.
OpenLoop describes itself as white-label telehealth infrastructure that can provide clinicians, technology, pharmacy connections, and billing. Its broad network capabilities do not establish that every Wellmedr treatment is available in every state.
The dispensing pharmacy is unresolved before intake. Wellmedr's privacy notice first calls Mycelium Pharmacy its fulfillment pharmacy, then identifies Logos Pharmacy in a partner summary, and later returns to Mycelium. The exact assigned pharmacy and compounder status must be confirmed for the selected prescription.
The public intake uses an online questionnaire followed by clinician review. Telehealth consent permits video, telephone, or asynchronous care. A live interaction, medical records, or laboratory work may still be requested based on the patient's state, history, and proposed treatment.
Payment is collected before clinical review. The operative policy says payment does not guarantee approval, a prescription, a particular drug or dose, or a treatment outcome. If the initial clinician does not approve treatment, Wellmedr promises an automatic full refund within seven business days.
Current checkout offers separate 21-day, three-month, six-month, and twelve-month choices. The longer terms are prepaid in full. Their displayed monthly figures are effective rates, not month-to-month charges.
Semaglutide costs $267 for three months, $438 for six months, or $588 for twelve months after the discounts currently applied in checkout. Those terms equal $89, $73, and $49 per month. Their unweighted mean is $70.33, displayed as Avg. $70 per month.
Tirzepatide costs $378 for three months, $738 for six months, or $1,068 for twelve months after the current checkout discounts. Those terms equal $126, $123, and $89 per month. Their unweighted mean is $112.67, displayed as Avg. $113 per month.
The 21-day cycle is excluded from both monthly averages. It costs $99 for semaglutide or $129 for tirzepatide and renews every 21 calendar days. If continuously active, the policy says as many as eighteen charges may occur in the first 365 days.
The current checkout automatically applies term-specific discounts to the prepaid choices. The three-month total receives $50 off, the six-month total receives $100 off, and the twelve-month total receives $350 off. These discounts and resulting totals need rechecking before any future publication.
Prepaid plans do not bill again during the paid term. The policy says a three-, six-, or twelve-month plan renews for the same full term only when automatic renewal was separately selected at checkout. Cancellation of renewal does not itself end fulfillment already purchased for the current term.
Current marketing pages contain incompatible offer language. One banner advertises $200 off every month or a $49 annual-plan rate for life, while another section says $150 off for life. No customer promotion is shown below the AllyRx CTA because the exact controlling offer and affiliate compatibility are not verified.
The weight-loss page also advertises a full money-back guarantee after 90 days without weight loss. The refund policy says Wellmedr does not guarantee an amount of weight loss and that lack of the desired result does not make an accepted medication order refundable. The operative policy controls this draft.
Wellmedr correctly states on its treatment-specific safety page that compounded semaglutide and tirzepatide are not FDA approved and are not FDA-approved generics. The exact formulation, ingredients, concentration, dose, pharmacy, and availability may vary.
FDA says compounded drugs are not reviewed before marketing for safety, effectiveness, or quality. FDA also lists semaglutide and tirzepatide as absent from the drug-shortage and 503B bulks lists, so routine shortage-based copying is no longer available. Patient-specific legal and clinical requirements still apply.
Wellmedr markets several other in-scope categories, but the public catalog relies heavily on product names. This review consolidates those offers into their real ingredients and keeps them out of price comparisons when a complete formula, dose, quantity, and current price are missing.
The primary oral testosterone-support product combines enclomiphene with anastrozole. Other versions add tadalafil, citrulline, NAD+, or oxytocin. These are combination compounds, not injectable testosterone replacement therapy and not separate canonical medications.
The sexual-health catalog includes formulas combining sildenafil and tadalafil, with some versions also listing vardenafil or apomorphine. The Black Pill page lists sildenafil 110 mg plus tadalafil 22 mg or a lower-strength combination. No single-ingredient price is inferred from those blends.
The hair-loss offer is one oral four-ingredient compound containing minoxidil, finasteride, biotin, and an incompletely specified nutrient component. It remains one editorial-only formula rather than separate minoxidil and finasteride price cards.
Most approved orders are advertised to ship within one to two business days after clinician approval, with standard delivery taking another three to five business days. Packages are described as plain and discreet. These are estimates rather than guaranteed arrival dates.
Wellmedr says it ships within the United States where its services are available and does not ship internationally. It does not publish one complete product-by-product state list. Eligibility must therefore be checked during intake rather than described as universal coverage.
The service does not currently take insurance. Major credit and debit cards are accepted, while HSA or FSA eligibility depends on the provider plan and card issuer. Third-party laboratory services may add a separate charge.
Support routes include support@wellmedr.com, info@wellmedr.com, 1-888-397-6905, account messaging, and clinician messaging. The refund policy lists Monday through Saturday hours from 9 AM to 10 PM ET, while a marketing footer gives different hours, so availability should be confirmed.
Cancellation can be submitted by email, portal, phone, or voicemail and is effective when received. An automatic receipt should arrive by email, with final confirmation targeted within one business day. A cancellation received after medication fulfillment starts may not make that medication refundable.
For prepaid plans, Wellmedr says unused future months may be refunded when medication fulfillment has not started for those months. Damaged, incorrect, lost, or clinically unusable shipments should be reported promptly, and the policy gives a seven-calendar-day reporting window for damaged or incorrect delivery.
- Only semaglutide and tirzepatide receive normalized cards; branded multi-ingredient formulas remain editorial context.
- Comparable prepaid terms average to $70 per month for semaglutide and $113 for tirzepatide.
- The separate 21-day plan is not monthly billing and may charge up to eighteen times during a year.
- The operative refund policy conflicts with current money-back and lifetime-discount marketing language.

